STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
ADVM ADVERUM BIOTECHNOLOGIES INCORPORATED StockScouter® Report
4
StockScouter® Score
ADVERUM BIOTECHNOLOGIES INCORPORATED, a micro cap company in the healthcare sector, is expected to underperform the market over the next six months with slightly higher than average risk
10 is the best possible rating. Learn more.
Summary
Positives
- Short-term relative price momentum exhibits moderate strength. Postive/Neutral
- Earnings growth in the past year is holding steady compared to earnings growth in the past three years. Neutral
Concerns
- The enterprise value-to-sales ratio is much higher than the average for comparably-sized companies in the StockScouter universe. Very Negative
- The multi-period measure of relative price change and consistency is well below average. Negative
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that micro cap stocks will be neutral, stocks will be , and healthcare stocks will be neutral.
Expected Risk/Return
Core Model Grades
D
C
F
F